Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Albany Molecular May Close Hungary Site
by Michael McCoy
January 16, 2012
| A version of this story appeared in
Volume 90, Issue 3
Albany Molecular Research Inc. may cut jobs at, and possibly close, its contract research facility in Budapest. AMRI says the chemistry facility, which employs about 100 people, has been hurt by customers’ preference to work with outsourcing labs that offer both biology and chemistry services. AMRI would shift work to its labs in Singapore or Hyderabad, India. The firm recently said it will reduce employment in its U.S. drug discovery operations as well (C&EN, Jan. 9, page 21). Separately, AMRI will provide small-molecule services for BioPontis Alliance, an investment fund that works with leading research institutes.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter